Marc R. Larochelle, MD, MPH

Assistant Professor, Medicine

Marc Larochelle
617.414.7399
801 Massachusetts Ave Crosstown Center

Biography

Marc Larochelle is a general internist and clinical investigator specializing in addiction medicine at BMC and an assistant professor of medicine at BUSM. Larochelle’s clinical and research interests focus on the safety of opioid prescribing and the recognition and treatment of opioid use disorders. As a health services researcher, Larochelle aims to leverage insights from large data sources and translate the findings into interventions that improve the quality and value of health care delivered. His special interests are Primary Care and Addiction Medicine.

Education

  • University of Pittsburgh School of Medicine, MD
  • Boston University School of Public Health, MPH
  • Duke University, BSE

Publications

  • Published on 6/27/2018

    Husain JM, LaRochelle M, Keosaian J, Xuan Z, Lasser KE, Liebschutz JM. Reasons for Opioid Discontinuation and Unintended Consequences Following Opioid Discontinuation Within the TOPCARE Trial. Pain Med. 2018 Jun 27. PMID: 29955866.

    Read at: PubMed
  • Published on 6/19/2018

    Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, Bagley SM, Liebschutz JM, Walley AY. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study. Ann Intern Med. 2018 Jun 19. PMID: 29913516.

    Read at: PubMed
  • Published on 6/14/2018

    Rose AJ, Bernson D, Chui KKH, Land T, Walley AY, LaRochelle MR, Stein BD, Stopka TJ. Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011-2015. J Gen Intern Med. 2018 Jun 14. PMID: 29948815.

    Read at: PubMed
  • Published on 6/1/2018

    Ladapo JA, Larochelle MR, Chen A, Villalon MM, Vassar S, Huang DYC, Mafi JN. Physician Prescribing of Opioids to Patients at Increased Risk of Overdose From Benzodiazepine Use in the United States. JAMA Psychiatry. 2018 Jun 01; 75(6):623-630. PMID: 29710086.

    Read at: PubMed
  • Published on 6/1/2018

    Haffajee RL, Mello MM, Zhang F, Zaslavsky AM, Larochelle MR, Wharam JF. Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages. Health Aff (Millwood). 2018 Jun; 37(6):964-974. PMID: 29863921.

    Read at: PubMed
  • Published on 4/21/2018

    McBain R, Rose AJ, LaRochelle MR. The U.S. opioid epidemic: One disease, diverging tales. Prev Med. 2018 Jul; 112:176-178. PMID: 29684417.

    Read at: PubMed
  • Published on 3/30/2018

    Bachhuber MA, Saloner B, LaRochelle M, Merlin JS, Maughan BC, Polsky D, Shaparin N, Murphy SM. Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs. Pain Med. 2018 Mar 30. PMID: 29618105.

    Read at: PubMed
  • Published on 12/1/2017

    Galbraith AA, Meyers DJ, Ross-Degnan D, Burns ME, Vialle-Valentin CE, Larochelle MR, Touw S, Zhang F, Rosenthal M, Balaban RB. Long-Term Impact of a Postdischarge Community Health Worker Intervention on Health Care Costs in a Safety-Net System. Health Serv Res. 2017 Dec; 52(6):2061-2078. PMID: 29130267.

    Read at: PubMed
  • Published on 9/1/2017

    Larochelle MR, Cocoros NM, Popovic J, Dee EC, Kornegay C, Ju J, Racoosin JA. Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System. J Opioid Manag. 2017 Sep/Oct; 13(5):315-327. PMID: 29199397.

    Read at: PubMed
  • Published on 9/1/2017

    Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, Guara G, O'Connor K, Alford DP, Parker V, Weiss RD, Samet JH, Crosson J, Cushman PA, Lasser KE. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial. JAMA Intern Med. 2017 Sep 01; 177(9):1265-1272. PMID: 28715535.

    Read at: PubMed

View 14 more publications: View full profile at BUMC

View all profiles